Thanks Tech. That was part of my fear of having significant number of deaths after 28 days. Your numbers below show tremendous mortality reduction with leronlimab but the power suffers due to low death count. I think if we are able to include 42 day data, then that will for sure include all 87 deaths reported as SAE.